Trulieve Cannabis OverviewTrack Trulieve Cannabis's EBIT ($-300M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowAs of Jun 30, 2026
Trailing 12 months ending Jun 30, 2026
Trulieve Cannabis posts a EBIT of $-300M as of June 2026. That is below the sector sector average of $-6.4M. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.
For its sector stocks, a EBIT near $-6.4M is typical. Trulieve Cannabis's $-300M is lower that level. That is roughly 4511.2% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.
EBIT is one piece of Trulieve Cannabis's financial statement story. At $-300M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.
Context for TRLV's EBIT usually means three checks: (1) trend versus prior periods, (2) level versus peers (average $-6.4M), and (3) consistency with growth and profitability. This page covers the first two; Trulieve Cannabis's other metric pages and overview cover the third.
